Multiple splicing factors are released from endogenous complexes during in vitro pre-mRNA splicing by Conway, G. C. et al.
  
1989, 9(12):5273. DOI: 10.1128/MCB.9.12.5273. Mol. Cell. Biol. 
G C Conway, A R Krainer, D L Spector and R J Roberts
 
pre-mRNA splicing.
endogenous complexes during in vitro 
Multiple splicing factors are released from
http://mcb.asm.org/content/9/12/5273
Updated information and services can be found at: 
These include:
CONTENT ALERTS
 more»cite this article), 
Receive: RSS Feeds, eTOCs, free email alerts (when new articles
http://mcb.asm.org/site/misc/reprints.xhtmlInformation about commercial reprint orders: 
http://journals.asm.org/site/subscriptions/To subscribe to to another ASM Journal go to: 
 o
n
 April 4, 2012 by M
AIN LIBRARY
http://m
cb.asm
.org/
D
ow
nloaded from
 
MOLECULAR AND CELLULAR BIOLOGY, Dec. 1989, p. 5273-5280
0270-7306/89/125273-08$02.00/0
Copyright © 1989, American Society for Microbiology
Multiple Splicing Factors Are Released from Endogenous
Complexes during In Vitro Pre-mRNA Splicing
GREG C. CONWAY,* ADRIAN R. KRAINER, DAVID L. SPECTOR, AND RICHARD J. ROBERTS
Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724
Received 1 June 1989/Accepted 22 August 1989
Pre-mRNA splicing occurs in a macromolecular complex called the spliceosome. Efforts to isolate
spliceosomes from in vitro splicing reactions have been hampered by the presence of endogenous complexes that
copurify with de novo spliceosomes formed on added pre-mRNA. We have found that removal of these large
complexes from nuclear extracts prevents the splicing of exogenously added pre-mRNA. We therefore
examined these complexes for the presence of splicing factors and proteins known or thought to be involved in
RNA splicing. These fast-sedimenting structures were found to contain multiple small nuclear ribonucleopro-
teins (snRNPs) and a fragmented heterogeneous nuclear ribonucleoprotein complex. At least two splicing
factors other than the snRNPs were also associated with these large structures. Upon incubation with ATP,
these splicing factors as well as Ul and U2 snRNPs were released from these complexes. The presence of
multiple splicing factors suggests that these complexes may be endogenous spliceosomes released from nuclei
during preparation of splicing extracts. The removal of these structures from extracts that had been
preincubated with ATP yielded a splicing extract devoid of large structures. This extract should prove useful
in the fractionation of splicing factors and the isolation of native spliceosomes formed on exogenously added
pre-mRNA.
Several factors have been identified that are necessary for
pre-mRNA splicing. The most extensively characterized of
these components are the major nucleoplasmic small nu-
clear ribonucleoprotein (snRNP) particles (Ul, U2, U4, U5,
and U6; for reviews, see references 23, 31, 43, 51, and 53).
Each snRNP is composed of a unique small nuclear RNA
(snRNA), and the RNAs of Ul, U2, U4, and U5 possess a
trimethyl guanosine cap at their 5' termini. There is evidence
that U4 and U6 snRNAs can reside in a single ribonucleo-
protein (RNP) complex (6, 24). All snRNPs contain seven
common polypeptides, designated B, B', D, D', E, F, and G.
In addition to the common proteins, Ul snRNP contains at
least three unique polypeptides, a 70-kilodalton (kDa) pro-
tein and proteins designated A and C. The U2 snRNP
contains at least two unique species, A' and B" (6, 7, 25, 42).
Evidence for the involvement of snRNPs in splicing de-
rives from the inhibition of in vitro splicing after the addition
of snRNP-specific antibodies (45, 55) and immunodepletion
of snRNPs (21, 35). The selective degradation of snRNAs by
oligonucleotide-directed RNase H cleavage also indicates
that snRNPs are involved in RNA splicing (1, 4, 5, 30, 35). In
vivo genetic studies in HeLa cells indicate that Ul snRNP
bind to 5' splice sites at least in part by base pairing between
the snRNA and pre-mRNA (56). Similar studies with the
yeast U2 RNA have shown that U2 snRNP binds to the
branch site also in part by base pairing (46). A similar role for
base pairing in branch site selection has not yet been shown
for mammalian U2 snRNP. Biochemical data have shown
that Ul snRNP protects 5' splice sites from nuclease diges-
tion and that U2 snRNP protects the branch point (4, 11, 43,
50). There is also suggestive evidence that U5 snRNP
associates with the 3' splice site; this interaction may be
mediated by a polypeptide called the intron-binding protein,
which has a binding preference for 3' splice sites and
cofractionates with U5 snRNP (10, 22, 54). It has recently
* Corresponding author.
been shown that purified snRNPs can complement a nu-
clease-treated extract for splicing (29).
Protein factors other than snRNPs are required for splic-
ing (30, 33, 34). Biochemical fractionation has identified
heat-labile factors required for both the first and second
steps of splicing and a heat-stable factor called SF2 (30).
None of the non-snRNP splicing factors has been exten-
sively purified. Studies indicate that two proteins, the heter-
ogeneous nuclear RNP (hnRNP) C proteins (Cl and C2),
which are major polypeptides bound to hnRNA in vivo, may
be involved in splicing (14). In vivo, the C proteins coexist
with other proteins in an RNP complex called hnRNP (for
reviews, see references 15 and 18). The most predominant
proteins in this complex other than the C proteins are four
proteins designated Al, A2, Bi, B2, two closely spaced
protein bands of 68 kDa, and a 120-kDa protein. Addition of
monoclonal antibodies specific for the hnRNP C proteins
and immunodepletion of the C-protein complex have been
shown to inhibit in vitro splicing (14). The inhibition data
suggest that C proteins or an associated factor(s) are neces-
sary for RNA splicing.
Analysis of in vitro splicing reactions by density gradients
or native gels indicates that many factors responsible for
RNA splicing are stably bound to pre-mRNA and form a
macromolecular complex called the spliceosome. Although
these techniques have shown the existence of a stable
splicing complex, they give rise to spliceosomes of insuffi-
cient purity to allow the identification of protein constitu-
ents. Splicing extracts contain endogenous complexes that
copurify with spliceosomes formed on exogenously added
pre-mRNA. The precise nature of these complexes is un-
known. In this study, we examined these endogenous com-
plexes and found that they contain several splicing factors
which are released in an ATP-dependent manner. Some of
these structures are the remnants ofRNP complexes known
to exist in vivo. The behavior of these endogenous RNP
complexes and the splicing factors they contain suggest
strategies that will be useful in the further purification of
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splicing factors and for the isolation of mammalian spliceo-
somes.
MATERIALS AND METHODS
Nuclear extract preparation and density gradient fraction-
ation. Nuclear extracts from HeLa cells were prepared as
previously described (17). For gradient fractionation, ex-
tracts in Dignam buffer D (100 mM KCl, 20 mM N-2-hydroxy-
ethylpiperazine-N'-2-ethanesulfonic acid [HEPES; pH 7.9],
0.2 mM disodium EDTA, 0.5 mM dithiothreitol) were sup-
plemented to final concentrations of 3.2 mM MgCl2, 0.5 mM
ATP, and 20 mM creatine phosphate or 3.2 mM MgCl2 alone
and incubated at 30°C for 30 min. Nuclear extracts were
layered onto 15 to 30% sucrose gradients in buffer D and
centrifuged in an SW28 rotor at 25,000 rpm for 16 h at 4°C.
Gradients were fractionated with a Buchler autodensiflow
IIC and simultaneously scanned at 260 nm with an ISCO UV
monitor. After fractionation, gradient fractions were dia-
lyzed against buffer D to remove sucrose and concentrated
with Centriprep centrifugal concentrators (Polysciences).
Pooled fractions smaller than 30S were concentrated to the
original extract volume, and fractions larger than 30S were
reduced to one-fifth the original volume.
RNA synthesis and in vitro splicing. Human ,-globin RNA
was synthesized as described by Krainer et al. (32) and
capped by the protocol of Konarska et al. (27). In vitro
splicing was performed as described by Krainer et al. (32),
using 15 ,ul of nuclear extract or gradient fractions in a total
volume of 25 1.l. Heat-inactivated extracts, micrococcal
nuclease-treated extracts, and the cytoplasmic S100 extract
were prepared as described by Krainer and Maniatis (30).
Complementation experiments were performed with 7.5 ,ul
of each fraction.
Immunoprecipitation of purified RNP complexes. For immu-
noprecipitation, HeLa cells were labeled with [35S]methi-
onine and [35S]cysteine. Cells were concentrated to one-fifth
the original volume in medium lacking methionine and grown
for 30 min to deplete intracellular methionine pools. Labeled
methionine and cysteine (35S-Trans; ICN Biochemicals)
were added to a final concentration of 50 ,XCi/ml, and the
cells were incubated for 6 h. After labeling, standard nuclear
extracts were prepared, fractionated on density gradients,
and dialyzed against buffer D to remove sucrose. Anti-
trimethyl guanosine cap (a-TMG) (29), Y12 (39), 2.31 (3),
and 4F4 (13) monoclonal antibodies were coupled to protein
A immobilized to Trisacryl (Pierce Chemical Co.). A mono-
clonal antibody specific for a rotavirus capsid protein (a gift
from K. Chan, Cold Spring Harbor Laboratory) was used in
control immunoprecipitations. Immobilized antibodies were
incubated at 4°C for 2 h with 5.5 x 106 cpm of pooled
gradient fractions less than 30S or equal cell equivalents of
pooled lower-gradient fractions. Antibody-antigen com-
plexes were washed five times with IP buffer containing 100
mM NaCl, 20 mM HEPES [pH 7.9], and 0.1% Triton X-100.
For analysis of RNA, the beads were suspended in 1 x PK
buffer (150 mM NaCl, 100 mM Tris hydrochloride [pH 7.5],
12.5 mM EDTA, 1% sodium dodecyl sulfate) containing 200
,ug of proteinase K per ml, incubated at 30°C for 15 min,
phenol extracted, and ethanol precipitated. For the analysis
of proteins, the beads were resuspended in sample buffer and
analyzed by sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis (36).
RESULTS
Splicing factors exist in fast-sedimenting structures and are
released under splicing conditions. Nuclear splicing extracts
were fractionated by sucrose gradient sedimentation to
resolve endogenous complexes. There were three peaks of
material absorbing at an optical density of 260 nm (OD260)
(less than 30S, 30S to 50S, and greater than 50S). When these
fractions were tested for the ability to splice human ,-globin
pre-mRNA in vitro, none was active (Fig. 1B, lanes 3, 4, 6,
and 8). However, material greater than 30S complemented
fractions less than 30S (Fig. 1B, lanes 5, 7, and 9). Both the
45S and greater-than-SOS fractions were effective in comple-
mentation (lanes 7 and 9). Next, endogenous complexes
from extracts preincubated under splicing conditions were
examined. This preincubation was at 30°C for 30 min in the
presence of Mg2+, ATP, and creatine phosphate. Extracts
treated under these conditions will be referred to as +ATP
extracts. These conditions reduced the 45S peak to one-third
of the original OD260 level. A test for splicing activity
indicated that fractions less than 30S would now splice
exogenous pre-mRNA (Fig. 1B, lane 10).
To investigate whether preincubation with ATP is neces-
sary to obtain the partitioning of splicing factors in fractions
less than 30S, we incubated splicing extracts either alone,
with Mg2+ (referred to as -ATP extracts), or under splicing
conditions (+ATP extracts) and fractionated them by den-
sity gradient sedimentation. Fractions less than and greater
than 30S were separately pooled and tested for the ability to
splice pre-mRNA. We found that in addition to Mg2+, both
ATP and creatine phosphate were necessary during the
preincubation to obtain splicing activity in fractions less than
30S (data not shown). A low level of splicing activity was
seen in less-than-30S fractions after preincubation with
Mg2+, and the 45S peak of material was reduced to two-
thirds of the original OD260 level. These phenomena were
probably due to residual ATP in splicing extracts.
snRNPs are among the splicing factors that shift in density
gradients. A splicing factor(s) was released from a fast-
sedimenting complex under splicing conditions (Fig. 1B).
The reduction of OD260-absorbing material in the 45S peak
after incubation suggested that a protein or RNA component
was either degraded or released from endogenous com-
plexes. Likely splicing factors with a large OD260 value that
might have been released were snRNPs. We therefore ex-
amined the distribution of snRNAs in gradient fractions of
unincubated splicing extracts, -ATP extracts, and +ATP
extracts. In unincubated extracts, most snRNAs existed in
large complexes 25S or faster (Fig. 2A). Ul snRNAs peaked
at the 45S position coincident with a smear of higher-
molecular-weight RNA, whereas U2 peaked at the 30S
position. Treatment of HeLa cells with actinomycin D 15
min before splicing extract preparation reduced the high-
molecular-weight smear to one-fourth the level in untreated
cells, indicating that the majority of this material was
hnRNA (data not shown). This material was also resistant to
DNase digestion. U4, U5, and U6 snRNAs were present in
fractions from 25S to the bottom of the gradient. Incubation
of nuclear extracts with Mg2+ (-ATP extracts) resulted in
the shift of a portion of the Ul snRNAs, whereas the other
snRNAs and hnRNA remained unaffected (Fig. 2B). Incu-
bation of splicing extracts under splicing conditions resulted
in a pronounced shift of Ul and U2 snRNAs to the top of
gradients, with no effect on the distribution of U4, U5, and
U6 snRNAs (Fig. 2C). Residual ATP in splicing extracts may
have contributed to the snRNA shift shown in Fig. 2B.
snRNPs remain intact after ATP incubation. Greater-than-
30S complexes containing Ul and U2 snRNAs disassembled
upon incubation with ATP (Fig. 2). As a result, Ul and U2
snRNAs remained at the top of gradients and existed either
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FIG. 1. Density gradient fractionation of splicing extracts and assay of splicing activity in the resulting fractions. (A) Splicing extracts (NE)
either unincubated or incubated under splicing conditions at 30°C for 30 min with Mg2+, creatine phosphate, and ATP (+ATP NE) were
fractionated on 15 to 30% sucrose gradients. After centrifugation, the gradients were fractionated and scanned for OD260-absorbing material.
The 30S and 50S positions of the gradients were determined by sedimentation of Escherichia coli ribosomal subunits in parallel gradients. (B)
Pools of gradient fractions shown in panel A were tested for splicing activity and for the ability to complement one another.
as protein-free snRNAs or as snRNP particles. To determine
whether snRNP proteins remain associated with snRNA
after incubation, immunoprecipitations were performed with
[35S]methionine-labeled splicing extracts. If snRNPs are
intact, then a-TMG monoclonal antibody (29), which recog-
nizes the unique cap structure of Ul, U2, U4, and U5
snRNAs, should precipitate snRNP polypeptides. a-TMG
antibody precipitated the A, B, B', and C snRNP polypep-
tides in less-than-30S and 45S gradient fractions from -ATP
extracts (Fig. 3A), indicating that these snRNP polypeptides
were bound to both fast- and slow-sedimenting snRNA
species. Similarly, the Y12 monoclonal antibody, which
recognizes B, B', and D proteins, precipitated the A through
C polypeptides and showed a roughly equal abundance of
these proteins in 45S and less-than-30S fractions. This result
correlates well with the results presented in Fig. 2B, which
shows an equal abundance of snRNAs in 45S and less-
than-30S fractions. The increased amounts of B and B'
polypeptides precipitated with Y12 as compared with a-
TMG antibodies in fractions less than 30S was probably due
to precipitation of RNA-free B and B' polypeptides before
their assembly into snRNP particles (19). The difference in
the amounts of precipitated core proteins seen with a-TMG
and Y12 antibodies in the 45S fractions may have been due
to decreased accessibility of the 5' cap of these snRNAs to
the a-TMG antibody.
Although in -ATP extracts the common snRNP polypep-
tides remain associated with snRNAs, incubation with ATP
might induce a dissociation of snRNPs from snRNA. This
was not the case for the A, B, B', and C proteins (Fig. 3B).
Even after ATP incubation and the abundant appearance of
snRNAs in less-than-30S fractions, these proteins remained
precipitable with a-TMG and Y12 monoclonal antibodies.
These results indicate that 45S snRNPs disaggregate into
individual snRNP particles rather than completely dissociat-
ing into RNA and proteins.
In addition to the common proteins, snRNPs contained
higher-molecular-weight proteins (bracketed in Fig. 3A).
These proteins appeared less abundant relative to the com-
mon polypeptides by Coomassie staining than by 35S label-
ing, possibly because of their rapid turnover and methionine
content. These proteins were specifically associated with
snRNP particles, as shown by their exclusive precipitation
with two snRNP-specific antibodies (Y12 and a-TMG) and
their absence with an antibody that recognizes hnRNP C
proteins (4F4 antibody) and a control monoclonal antibody
against a rotaviral capsid protein. Close scrutiny of these
high-molecular-weight proteins indicated differences in the
polypeptide composition of less-than-30S and greater-than-
30S snRNPs. In addition, ATP incubation affected the abun-
dance of some of these proteins relative to the levels of the
common snRNP polypeptides. These phenomena are under
further investigation.
The hnRNP C proteins do not shift to upper-gradient
fractions upon incubation under splicing conditions. To deter-
mine whether the hnRNP C proteins shift in density gradi-
ents under splicing conditions, immunoprecipitations using
the 4F4 monoclonal antibody specific for the hnRNP C
proteins were performed. Most of the Cl and C2 proteins in
-ATP extracts resided in fractions greater than 30S (Fig.
3A). Upon incubation with ATP, a portion of the C proteins
in fractions greater than 50S shifted to the 45S fraction (Fig.
3B). Gradient fractions less than 30S contained little immu-
noprecipitable C protein. Immunoprecipitation recovered
not only the C proteins but also several higher-molecular-
size species, among them doublets at approximately 68 kDa
VOL. 9, 1989 5275
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FIG. 2. Sedimentation analysis of snRNAs in splicing extracts.
Unincubated splicing extracts (A), extracts incubated with Mg2+
alone (B), and extracts incubated under splicing conditions (C) were
fractionated on 15 to 30% sucrose gradients. The RNA in each
fraction was analyzed on 8% denaturing gels and visualized by
ethidium staining.
and at 120 kDa. The coprecipitation of these proteins was
most prominent in fractions greater than 50S.
Heat-labile splicing factors and SF2 shift in density gradi-
ents. We examined the sedimentation behavior of splicing
factors other than the snRNPs. Gradient fractions were
assayed for the presence of heat-labile factors by comple-
mentation of a heat-inactivated extract and for SF2 (30) by
complementation of an S100 extract missing this factor.
Fractions greater than 30S from -ATP extracts contained
active heat-labile factors (Fig. 4, lane 3) and SF2 (lane 7) but
were missing from upper-gradient fractions (lanes 2 and 6).
In unincubated extracts, heat-labile factors and SF2 were
also exclusively found in lower-gradient fractions (data not
shown). When nuclear extracts were preincubated under
splicing conditions, heat-labile factors, especially the heat-
labile factor required for the second step of splicing desig-
a
FIG. 3. Immunoprecipitation of snRNPs and hnRNPs from frac-
tionated nuclear extracts. HeLa cells were labeled in vivo with
[35S]methionine, and nuclear extracts were prepared. Splicing ex-
tracts were incubated either with Mg2" alone (A) or under splicing
conditions (B). Extracts were then fractionated on sucrose gradi-
ents, and equal cell equivalents of pooled fractions were used in
immunoprecipitations with a-TMG (recognizes the cap structure of
Ul to U5 snRNAs), Y12 (recognizes B, B', and D snRNP proteins),
4F4 (recognizes the hnRNP C proteins), and a control antibody
(recognizes a rotavirus capsid protein). The lanes marked Total
contained 1/50 the protein in fractions used for immunoprecipita-
tion. Molecular size markers are indicated on the left. The vertical
bracket in panel A marks the position of high-molecular-weight
snRNP proteins.
nated SF3 (30), and SF2 were reduced in lower-gradient
fractions (lanes 4 and 8). These factors were now present at
the top of gradients, since these upper-gradient fractions
were fully competent for splicing (Fig. 1B, lane 10).
Cleared extracts can be used to identify spliceosomal com-
ponents. To demonstrate the utility of cleared splicing ex-
tracts, we analyzed the snRNA composition of spliceo-
somes. Splicing reactions were performed with cleared
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FIG. 4. Assay for SF2 and heat-labile factors in gradient frac-
tions. Splicing extracts incubated either with Mg2' alone (-ATP
NE) or under splicing conditions (+ATP NE) were fractionated on
sucrose gradients, and pooled fractions were assayed for comple-
mentation of a heat-inactivated extract (ANE; lanes 2 to 4) or an
S100 extract lacking SF2 (lanes 6 to 8). Reactions with heat-
inactivated extract and with an S100 extract are shown in lanes 1 and
5, respectively.
extracts and human 3-globin pre-mRNA and subjected to
sucrose gradient sedimentation. A mock splicing reaction
lacking exogenous splicing substrate did not result in the
formation of snRNP complexes that sedimented into lower-
gradient fractions (Fig. SA). However, addition of pre-
mRNA caused a shift of Ul, U2, U5, and U6 snRNAs into
the gradient (compare lanes 17 of Fig. 5A and B). The
sedimentation of these snRNPs into this region was coinci-
dent with the presence of pre-mRNA and splicing interme-
diates (Fig. 5C). Although the migration of U4 snRNA was
shifted into the gradient by addition of pre-mRNA, this
snRNP did not peak with splicing intermediates. This obser-
vation is consistent with reports that U4 snRNP dissociates
from the spliceosome during RNA splicing (12, 28, 37, 48).
DISCUSSION
We have assayed RNP complexes found in splicing ex-
tracts for the ability to splice exogenous pre-mRNA as well
as for the presence of specific splicing factors. We have
found that splicing extracts contain at least two types of
RNP complexes larger than 30S; one of these structures
contains snRNPs, whereas the other is an hnRNP complex.
The majority of snRNPs in unincubated extracts sediment
faster than 25S. The nature of these large snRNP complexes
is unknown. However, they do not appear to result from
interactions with hnRNA. Incubation with Mg2+, ATP, and
creatine phosphate converts almost all of the Ul and U2
snRNPs into slow-sedimenting structures. There are subtle
differences in the high-molecular-weight polypeptide compo-
- U2
-:4
%J,
C;
FIG. 5. Sedimentation analysis of snRNPs in splicing reactions
with cleared nuclear extracts. One-hour splicing reactions (2.5 ml,
total volume) containing either no RNA (A) or 2.5 ,ug of 32P-labeled
human 0-globin pre-mRNA (B) were performed with cleared ex-
tracts. Reactions were analyzed on 15 to 30% sucrose gradients and
fractionated, and the RNA in odd-numbered fractions was analyzed
on 8% denaturing gels. Compare lanes 17 of panels A and B
(arrowhead). One-fifth of the RNA in each odd-numbered fraction
was analyzed on 5% denaturing gels and autoradiographed (C).
sitions of fast- and slow-sedimenting snRNPs. ATP incuba-
tion also affects the abundance of these proteins relative to
the abundance of the common snRNP proteins. A 260-kDa
protein that is associated with snR7, the yeast U5 homolog,
has recently been identified (40). The mammalian homolog of
this protein may be represented among the high-molecular-
weight species identified in Fig. 3.
snRNPs may be dynamic structures consisting of a stable
core of several polypeptides to which other polypeptides are
more loosely or transiently associated. Some proteins might
be necessary for pre-mRNA binding, while others might be
required for exon alignment, cleavage, ligation and, in some
instances, alternative splicing. Such a model is reminiscent
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of the ribosome, in which a structure with a fixed core
acquires and releases auxiliary polypeptides. snRNPs iso-
lated during splicing extract preparation may be heteroge-
neous, reflecting their dynamic state in vivo. Preincubation
of splicing extracts without the addition of pre-mRNA may
synchronize snRNPs at a point just before their participation
in splicing. The Ul and U2 snRNPs may exist in this primed
state as less-than-30S structures.
snRNP complexes or aggregates were reported by Konar-
ska and Sharp (28). These studies used native gels and
indicated a cluster of slowly migrating bands containing U2
snRNA. Upon ATP incubation, these bands were shifted to
more rapidly migrating species. These band shifts may
reflect the conversion of greater-than-30S U2 snRNPs to
less-than-30S structures. However, the proportion of U2
snRNPs that shift, as indicated by native gels, is much less
than that which we detect. Native gel analysis also showed
the comigration of U4, U5, and U6 snRNPs, and it was
suggested that these snRNPs can exist in a single complex.
The cosedimentation in sucrose gradients of U4, U5, and U6
that we report may be the result of interactions between
these particles. Konarska and Sharp also report the ATP-
dependent dissociation of U4 snRNP from this U4-U5-U6
snRNP complex. Whereas ATP incubation results in a
dramatic shift of Ul and U2 snRNPs (Fig. 2), we do not
detect shifts in the migration of the other snRNPs that might
result from the dissociation of a U4-U5-U6 complex. In
addition we do not detect an ATP-dependent association of
these snRNPs, as has been shown for the yeast U4, U5, and
U6 snRNA homologs (40). The smearing of U4, U5, and U6
across our density gradients suggests that if these snRNPs
exist in a complex, this complex is heterogeneous. Interest-
ingly, we find that the U4, U5, and U6 snRNPs that sediment
less than 30S are sufficient for RNA splicing.
Konarska and Sharp (28) reported that Ul snRNP is a
slowly sedimenting structure in density gradients and mi-
grates in native gels more rapidly than do any of the other
snRNPs. Our results show that in unincubated extracts, Ul
snRNP exists as a fast-sedimenting complex. We believe
that the gradient and electrophoretic conditions used by
Konarska and Sharp (28) may cause the dissociation of Ul
snRNP from endogenous complexes. There is evidence that
the conditions used by Konarska and Sharp weaken inter-
actions of Ul snRNP with other components of the splicing
apparatus, since their conditions fail to detect Ul snRNP in
spliceosomes. On the other hand, different electrophoretic
conditions can demonstrate the presence of Ul snRNP in
spliceosomes (57). This destabilizing effect may extend to
interactions between Ul snRNP and the endogenous com-
plexes of splicing extracts, explaining the discrepancy be-
tween our results and those of Konarska and Sharp (28).
The sedimentation of snRNPs in lower-gradient fractions
reported in this paper is similar to that reported earlier by
Lerner et al. (38) and Spector et al. (52). The fast sedimen-
tation of snRNPs reported by others was interpreted to be
the result of an interaction between snRNPs and hnRNA.
The similar phenomena that we observe in splicing extracts
originally led us to the same conclusion. However, immu-
noprecipitations with anti-snRNP and anti-hnRNP C-protein
antibodies suggest that in splicing extracts snRNPs and
hnRNA reside in different complexes. The studies of Lerner
et al. and Spector et al. were performed with a nuclear
extract that was not subjected to high salt and was produced
by sonication of nuclei. This technique is more likely to
protect and release snRNP-hnRNA complexes than is the
high-salt extractions used to make splicing extracts. There-
fore, the structures seen by others may be extracted com-
plexes of interacting snRNPs and hnRNA that existed in
vivo, whereas the greater-than-30S structures we observe
may be similar, but snRNP and hnRNP components have
been dissociated. We cannot rule out the possibility that
the immunoprecipitation conditions we used may disrupt
snRNP-hnRNA associations. However, the immunoprecip-
itation conditions we use are very gentle (100 mM NaCl, 20
mM HEPES [pH 8.0], 0.1% Triton X-100) and are compat-
ible with splicing (data not shown).
The other RNP structure we have characterized is a
remnant of the hnRNP complex. In splicing extracts, there is
a low concentration of free hnRNP C proteins. The majority
of these proteins are complexed with endogenous hnRNA
and sediment greater than 30S. The size of this endogenous
hnRNA (500 to 800 nucleotides) is roughly the same as that
associated with isolated hnRNP complexes (13, 41). Two
polypeptides shown to be associated with C proteins in vivo
(13), a 68-kDa and a 120-kDa protein, interact with C
proteins in vitro, as shown by coimmunoprecipitation with
4F4 monoclonal antibody. Incubation of splicing extracts
with ATP does not affect the association of C protein with
hnRNA. Interestingly, the hnRNP A- and B-group polypep-
tides are not associated with C proteins in splicing extracts.
This can be explained by the salt conditions used in prepar-
ing splicing extracts. Both the A- and B-group polypeptides
are released from hnRNA by salt concentrations 200 mM or
higher (2), roughly the concentration used during splicing
extract preparation. It is interesting that these proteins do
not reassociate with hnRNA after dialysis to low-salt condi-
tions. These proteins may either remain soluble or form
insoluble helical filaments, an alternate structural form of
these proteins (41). These filaments would be removed
during one of the centrifugation steps in extract preparation.
We have also found that protein factors necessary for
splicing, namely, heat-labile factors and SF2, shift to upper-
gradient fractions after ATP incubation. It is not known
whether these factors in unincubated extracts are associated
with greater-than-30S snRNPs, C-protein complexes, both,
or other structures. A recent study has shown that SF2 is not
associated with snRNPs immunopurified from unincubated
extracts (29). It is possible that after incubation, heat-labile
factors and SF2 associate with less-than-30S snRNPs.
The work of Reed et al. (49) also indicates that splicing
extracts contain endogenous RNP particles. Using gel filtra-
tion chromatography, they isolated fractions containing
spliceosomes formed on exogenously added RNA. In these
fractions, they observed 40- to 60-nm particles that were
micrococcal nuclease sensitive, and these fractions con-
tained snRNPs and endogenous hnRNA. These particles
were observed whether or not pre-mRNA was added to
extracts, indicating that the particles arose predominantly
from endogenous material. The characteristics of the parti-
cles described by Reed et al. are similar to those of the RNPs
we have isolated. Density gradient centrifugation may ac-
complish a fractionation similar to that achieved by gel
filtration chromatography. The structures described by Reed
et al., as judged by quantitation from electron microscopy,
seem to form only in the presence of ATP. In contrast, we
find that the majority of 50S to 60S snRNPs, those being
mainly Ul and U2, are converted to less-than-30S structures
by ATP. After ATP incubation, the majority of material that
remains is the hnRNP complex and a small fraction of the
snRNPs. This material may be identical to that seen by Reed
et al.
Efforts to isolate yeast spliceosomes have also been com-
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ENDOGENOUS COMPLEXES OF SPLICING EXTRACTS
plicated by the presence of material in splicing extracts that
cosediment with spliceosomes formed on exogenously
added pre-mRNA. It was noted by Brody and Abelson (9)
that the sedimentation rate of the yeast spliceosome is
influenced by monovalent cation concentration. Taking ad-
vantage of this phenomena, Clark et al. (16) have developed
a salt-shift purification scheme for isolating yeast spliceo-
somes. Splicing reactions are first sedimented in high salt
containing glycerol gradients. The spliceosome peak is then
sedimented in a low-salt-containing gradient. In each gradi-
ent, the spliceosome peaks in different fractions as a result of
the salt effect, with the net result of purifying spliceosomes
from contaminating structures. By use of this method,
spliceosomes have been purified sufficiently to allow ultra-
structural analysis of complexes formed on exogenously
added pre-mRNA. Conceptually, there are parallels between
the salt-shift scheme and the preclearing of splicing extracts
that we describe. Both methods try to enrich for spliceo-
somes formed on added pre-mRNA by the removal of
endogenous complexes.
In conclusion, mammalian splicing extracts contain
endogenous complexes that possess splicing factors. These
factors are released during in vitro splicing reactions, and
this release is probably a prerequisite for the splicing of
exogenous pre-mRNA. These endogenous complexes may
be spliceosomes or portions of that complex released from
nuclei during extract preparation. However, barring a func-
tional test which determines that these endogenous struc-
tures splice endogenous RNA, we do not feel that the term
spliceosome should be attributed to the structures we have
seen. It cannot be concluded that endogenous RNP com-
plexes of nuclear extracts are native structures unless this
hypothesis is tested by a functional assay. The hnRNP
complex has undergone partial dissociation during extract
preparation, and large snRNP complexes could result from
artifactual aggregation. Despite this uncertain etiology, the
phenomena we report should have important implications
for the purification of splicing factors. Prior ATP incubation
may facilitate the separation of splicing factors from contam-
inants. The use of extracts cleared of endogenous complexes
should be valuable in the isolation of native spliceosomes,
since splicing reactions with this extract will contain only a
single large structure, the splicing complex formed on exog-
enous pre-mRNA. We have demonstrated the utility of this
method in the analysis of the snRNA components in spliceo-
somes. A detailed analysis of the polypeptide composition of
spliceosomes is in progress.
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